0.00Open0.10Pre Close0 Volume14 Open Interest12.50Strike Price0.00Turnover86.69%IV28.31%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0557Delta0.0291Gamma172.96Leverage Ratio-0.0088Theta-0.0006Rho-9.63Eff Leverage0.0050Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet